Real-time enrollment status for this retinitis pigmentosa clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:05 PM UTC
| NCT Number | NCT07502664 |
| Recruiting Status | Recruiting |
| Condition | Retinitis Pigmentosa |
| Phase | Clinical Trial |
| Target Enrollment | 25 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Ray Therapeutics, Inc. |
| Last Updated on CT.gov | March 31, 2026 (Mar 31, 2026) |
As of July 13, 2026: Clinical trial NCT07502664 is currently recruiting participants. This clinical trial study for retinitis pigmentosa is actively seeking new participants at 1 location across the United States. The study is sponsored by Ray Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07502664 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07502664 was last updated Mar 31, 2026 (March 31, 2026). HelloStudys verifies this status automatically.